Search

Your search keyword '"Kim Gillies"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Kim Gillies" Remove constraint Author: "Kim Gillies" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
18 results on '"Kim Gillies"'

Search Results

1. A Partial Near-infrared Guide Star Catalog for Thirty Meter Telescope Operations

2. The Infrared Imaging Spectrograph (IRIS) for TMT: final design development of the data reduction system

3. Quality assurance and verification of TMT observatory software

4. The operations of the Thirty Meter Telescope

5. TMT common software final construction update

6. Design and construction update on the Thirty Meter Telescope executive software system

7. The Infrared Imaging Spectrograph (IRIS) for TMT: final software design update

8. The Infrared Imaging Spectrograph (IRIS) for TMT: advancing the data reduction system

9. The Infrared Imaging Spectrograph (IRIS) for TMT: closed-loop adaptive optics while dithering

10. A Road Map for the Generation of a Near-Infrared Guide Star Catalog for Thirty Meter Telescope Observations

11. A database for TMT interface control documents

12. TMT common software update

13. TMT approach to observatory software development process

14. The Infrared Imaging Spectrograph (IRIS) for TMT: motion planning with collision avoidance for the on-instrument wavefront sensors

15. A phase II trial of durvalumab (Medi 4736) in advanced endometrial cancer: PHAEDRA

16. Baseline quality of life (QOL) as a predictor of stopping chemotherapy early, and of overall survival, in platinum-resistant/refractory ovarian cancer (PRROC): The GCIG symptom benefit study (SBS)

17. Is it time to change the primary endpoint in clinical trials in recurrent ovarian cancer (ROC)?: Symptom burden and outcomes in patients with platinum resistant/refractory (PRR) and potentially platinum sensitive ROC receiving ≥ 3 lines of chemotherapy (PPS ≥ 3)—The Gynecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS)

18. Baseline predictors of early treatment failure in patients with platinum resistant/refractory (PRR) and potentially platinum sensitive (PPS ≥ 3) recurrent ovarian cancer (ROC) receiving ≥ 3 lines of chemotherapy: The Gynaecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS)

Catalog

Books, media, physical & digital resources